These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 17981226
1. The role of the woodchuck model in the treatment of hepatitis B virus infection. Kulkarni K, Jacobson IM, Tennant BC. Clin Liver Dis; 2007 Nov; 11(4):707-25, vii. PubMed ID: 17981226 [Abstract] [Full Text] [Related]
2. Establishing a new animal model for hepadnaviral infection: susceptibility of Chinese Marmota-species to woodchuck hepatitis virus infection. Wang BJ, Tian YJ, Meng ZJ, Jiang M, Wei BQ, Tao YQ, Fan W, Li AY, Bao JJ, Li XY, Zhang ZM, Wang ZD, Wang H, Roggendorf M, Lu MJ, Yang DL. J Gen Virol; 2011 Mar; 92(Pt 3):681-91. PubMed ID: 21084496 [Abstract] [Full Text] [Related]
3. Fluctuation of the cytokine expression in the liver during the chronic woodchuck hepatitis virus (WHV) infection is not related to viral load. Schildgen O, Fiedler M, Dahmen U, Li J, Lohrengel B, Lu M, Roggendorf M. Immunol Lett; 2006 Jan 15; 102(1):31-7. PubMed ID: 16046239 [Abstract] [Full Text] [Related]
4. Characterization of interleukin 8 in woodchucks with chronic hepatitis B and hepatocellular carcinoma. Liu CJ, Huang YJ, Chen HL, Lin HT, Lin HL, Kuo ML, Huang JL, Chen DS, Chen PJ, Wu HL. Genes Immun; 2009 Jan 15; 10(1):27-36. PubMed ID: 18971938 [Abstract] [Full Text] [Related]
5. Liver-targeted antiviral nucleosides: enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infection in vivo. Korba BA, Xie H, Wright KN, Hornbuckle WE, Gerin JL, Tennant BC, Hostetler KY. Hepatology; 1996 May 15; 23(5):958-63. PubMed ID: 8621175 [Abstract] [Full Text] [Related]
6. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks. Lu M, Hilken G, Yang D, Kemper T, Roggendorf M. J Virol; 2001 Apr 15; 75(8):3811-8. PubMed ID: 11264370 [Abstract] [Full Text] [Related]
7. In vitro activation of woodchuck lymphocytes measured by radiopurine incorporation and interleukin-2 production: implications for modeling immunity and therapy in hepatitis B virus infection. Cote PJ, Gerin JL. Hepatology; 1995 Sep 15; 22(3):687-99. PubMed ID: 7544755 [Abstract] [Full Text] [Related]
8. Lack of WHV integration nearby N-myc2 and in the downstream b3n and win loci in a considerable fraction of liver tumors with activated N-myc2 from naturally infected wild woodchucks. Bruni R, Conti I, Villano U, Giuseppetti R, Palmieri G, Rapicetta M. Virology; 2006 Feb 05; 345(1):258-69. PubMed ID: 16271377 [Abstract] [Full Text] [Related]
9. Molecular characterization of woodchuck interleukin 15 (wIL-15) and detection of its expression in liver samples of woodchucks infected with woodchuck hepatitis virus (WHV). Wang B, Lohrengel B, Lu Y, Meng Z, Xu Y, Yang D, Roggendorf M, Lu M. Cytokine; 2005 Dec 21; 32(6):296-303. PubMed ID: 16406557 [Abstract] [Full Text] [Related]
10. Pre-acute hepadnaviral infection is associated with activation-induced apoptotic death of lymphocytes in the woodchuck (Marmota monax) model of hepatitis B. Gujar SA, Jenkins AK, Macparland SA, Michalak TI. Dev Comp Immunol; 2010 Sep 21; 34(9):999-1008. PubMed ID: 20451550 [Abstract] [Full Text] [Related]
11. Infection Patterns Induced in Naive Adult Woodchucks by Virions of Woodchuck Hepatitis Virus Collected during either the Acute or Chronic Phase of Infection. Freitas N, Lukash T, Rodrigues L, Litwin S, Kallakury BV, Menne S, Gudima SO. J Virol; 2015 Sep 21; 89(17):8749-63. PubMed ID: 26063428 [Abstract] [Full Text] [Related]
12. Animal models of hepatocellular carcinoma: hepadnavirus-induced liver cancer in woodchucks. Ponzetto A, Forzani B. Ital J Gastroenterol; 1991 Nov 21; 23(8):491-3. PubMed ID: 1751825 [Abstract] [Full Text] [Related]
13. The woodchuck: a model for therapeutic vaccination against hepadnaviral infection. Roggendorf M, Yang D, Lu M. Pathol Biol (Paris); 2010 Aug 21; 58(4):308-14. PubMed ID: 20646874 [Abstract] [Full Text] [Related]
14. Antiviral activity of ganciclovir, 9-(1,3-dihydroxy-2-propoxymethyl) guanine against woodchuck hepatitis virus: quantitative measurement of woodchuck hepatitis virus DNA using storage phosphor technology. Zahm FE, Bonino F, Giuseppetti R, Rapicetta M. Ital J Gastroenterol Hepatol; 1998 Oct 21; 30(5):510-6. PubMed ID: 9836108 [Abstract] [Full Text] [Related]
15. Hepadnavirus-induced liver cancer in woodchucks. Gerin JL, Cote PJ, Korba BE, Tennant BC. Cancer Detect Prev; 1989 Oct 21; 14(2):227-9. PubMed ID: 2695243 [Abstract] [Full Text] [Related]
16. Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity. Wang J, Gujar SA, Cova L, Michalak TI. J Virol; 2007 Jan 21; 81(2):903-16. PubMed ID: 17079319 [Abstract] [Full Text] [Related]
17. Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model. Roggendorf M, Schulte I, Xu Y, Lu M. J Viral Hepat; 2007 Nov 21; 14 Suppl 1():51-7. PubMed ID: 17958643 [Abstract] [Full Text] [Related]
18. Hepatic expression of the woodchuck hepatitis virus X-antigen during acute and chronic infection and detection of a woodchuck hepatitis virus X-antigen antibody response. Jacob JR, Ascenzi MA, Roneker CA, Toshkov IA, Cote PJ, Gerin JL, Tennant BC. Hepatology; 1997 Dec 21; 26(6):1607-15. PubMed ID: 9398005 [Abstract] [Full Text] [Related]
19. The woodchuck model of hepatitis B virus infection. Tennant BC, Gerin JL. ILAR J; 2001 Dec 21; 42(2):89-102. PubMed ID: 11406711 [Abstract] [Full Text] [Related]
20. Persistence of isolated antibodies to woodchuck hepatitis virus core antigen is indicative of occult infection. Coffin CS, Pham TN, Mulrooney PM, Churchill ND, Michalak TI. Hepatology; 2004 Nov 21; 40(5):1053-61. PubMed ID: 15382154 [Abstract] [Full Text] [Related] Page: [Next] [New Search]